Serum carnitine profile changes after open heart surgery in children with CHDs

Wail Ali1, David Rosen2

  • 1Department of Pediatrics, Section of Pediatric Critical Care, Riley Children's Health, Indiana University School of Medicinehttps://ror.org/03vzvbw58, Indianapolis, IN, USA.

Cardiology in the Young
|December 17, 2025
PubMed

Insights

This study found that children undergoing open-heart surgery experience changes in L-carnitine levels, impacting myocardial metabolism. These carnitine disturbances may affect postoperative cardiac recovery in pediatric patients.

Area of Science:

  • Biochemistry
  • Pediatric Cardiology
  • Metabolic Research

Background:

  • L-carnitine is vital for heart muscle energy production.
  • Depletion of L-carnitine can impair cardiac function.
  • Understanding carnitine metabolism is crucial for managing patients undergoing cardiac surgery.

Purpose of the Study:

  • To evaluate serum carnitine profiles in young children before and after open-heart surgery.
  • To investigate the relationship between cardiopulmonary bypass and carnitine levels.
  • To assess the clinical implications of perioperative carnitine changes on cardiac recovery.

Main Methods:

  • Prospective observational study of 26 children (<36 months) undergoing elective open-heart surgery.
  • Serum levels of free carnitine and acylcarnitine were measured.
  • Measurements were taken preoperatively and up to 24 hours postoperatively.

Main Results:

  • A significant decrease in free carnitine was observed postoperatively.
  • The acylcarnitine-to-free carnitine ratio increased significantly after surgery.
  • These changes correlated with the duration of cardiopulmonary bypass.

Conclusions:

  • Perioperative alterations in carnitine metabolism occur in children undergoing open-heart surgery.
  • Cardiopulmonary bypass duration influences these metabolic disturbances.
  • These findings suggest a potential role for carnitine in supporting postoperative cardiac function in pediatric patients.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
362
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
758
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
534
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
436
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
257
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
313